The Quest for a True AIDS Cure — in a Coral Reef

In the search for a way to eliminate the AIDS virus from every cell in the body, scientists are pursuing promising compounds from under the sea.

7:00 AM

Author | Kara Gavin

Nef proteins stopping healthy proteins form alerting the immune system of HIV

It was the height of the AIDS crisis, in the mid-1980s. As a young medical student in Baltimore, Kathleen Collins, M.D., Ph.D., witnessed the front lines of the battle against a frightening new epidemic, in a city that was especially hard-hit.

MORE FROM THE LAB: Subscribe to our weekly newsletter

She saw babies born to mothers who had the disease — coming into the world carrying a deadly virus no one understood, no vaccine could prevent and no drugs could treat.

The helplessness of that time inspired Collins to join the fight against HIV, to figure out its mysteries at the deepest levels.

Thirty years later, as both an AIDS doctor and a scientist at the University of Michigan Medical School, she's still on that quest.

AIDS still has no cure, and despite many advances in treatment, 35 million people worldwide still live with HIV lurking deep in their bodies and can still spread it. Those with access to treatment must take handfuls of expensive, sometimes toxic medications every day, without fail, for the rest of their lives.

Meanwhile, 2 million people worldwide are infected annually.

"Healthy young people continue to be sickened by the virus and require lifelong care," Collins says. "Even though therapies have turned HIV into a chronic disease, it's still contagious. Vaccines have been 30 percent effective, at most, because the virus mutates so quickly. This is the only virus where 100 percent of people who become infected are infected for life. Moving toward a true cure would be transformative."

Collins studies the virus's ability to fool the body's immune system and to hide out in remote corners of an infected person's body like a fugitive from justice.

Even in people treated daily for years with the most advanced combinations of AIDS drugs, HIV manages to evade the immune system's watchdogs. Collins and others have shown that it retreats to long-lived cells and keeps them from revealing its presence.

In recent years, the search for a solution to flush HIV out of hiding has led Collins and her team to a strange but promising place: the ocean's coral reefs.

If this approach works, we could essentially harness a person's own natural immune response to wipe HIV out of the body.
Kathleen Collins, M.D., Ph.D.

A 'promising' approach

Working with U-M colleague David Sherman, Ph.D., and his team, they're zeroing in on promising drugs made from bacteria that live side by side with coral. Called marine actinomycetes, they have proved to be a potent source of other antimicrobial drug candidates. In the case of HIV, it's the metabolites made by the bacteria during their life span — in essence, their waste products — that turn out to be good drug candidates.

The potential new drugs target a protein made by HIV, called Nef. Once thought to be unimportant, Nef is a key player in HIV's ability to stay hidden. It keeps the body's "killer" T cells — the storm troopers of the immune system — from discovering where HIV still lurks.

Over the past decade, Collins and her team have shown how HIV uses Nef to avoid blowing its cover and bring the immune system's swift justice down on its hiding places. Nef attaches to the cell's own invader-fighting infrastructure, forcing cells to drag these important cellular components into their inner garbage-disposal systems. That means the cells can't raise the red flag to bring in the killer T cells.

The coral bacteria, it turns out, make substances that can interfere with Nef and stop it from working. The U-M team discovered this after checking a huge library of potential drugs for their ability to stop Nef — finding none. The U-M Center for Chemical Genomics, based at the Life Sciences Institute, helped the team zero in on the compounds coral-dwelling bacteria make.

After starting with 10 promising compounds, the scientists have whittled the possibilities down to three that seem to hold the most potential to inhibit Nef.

Now, they're starting to test the drugs' ability to function in living cells and tissues. The first results have been extremely promising — the most potent inhibition of Nef ever seen.

"We're still at the early stages of testing these candidates, but they're very promising," Collins says. "No one has ever developed a Nef inhibitor with this level of activity. If this approach works, we could essentially harness a person's own natural immune response to wipe HIV out of the body."

One of the biggest challenges, she notes, is getting the bacteria to produce enough of the compounds to carry out their work. The scientists are also working to figure out the molecular structure of the compounds, in hopes they could build them from scratch one day and cut the bacteria out of the process.

If their continued tests succeed, further research in animals would be needed before any human could try the drugs. If they succeed in inhibiting Nef and making HIV-infected cells reveal the virus's presence, their work could translate into other fields, such as efforts to find a cancer vaccine that can flush cancer cells out of their hiding places.

U-M's A. Alfred Taubman Medical Research Institute and the National Institutes of Health are funding the work at this time. But Collins says it will take far more money to perform the experiments that could truly test the three most promising drug candidates she and Sherman have identified.

"Taking something from bacteria and making it into a drug requires a tremendous investment," she says. Eventually, the goal would be to partner with industry to do clinical testing in patients if her team can show enough anti-HIV activity in preclinical testing.

But as Collins has learned in the 30 years she's been involved in the fight against AIDS, nothing happens quickly when you're up against such a formidable foe.

"AIDS won't go away until we have a true vaccine or cure," she says. "The fight may not seem to have as much urgency as it did 30 years ago, but it's still an urgent issue."

Photo caption: Normal cells form a halo of a protein called MHC-1 around themselves (top row, red rings), which lets them send up a "red flag" to the immune system if they become infected with HIV. But  once HIV has entered a cell, it produces a protein called Nef that keeps the cells from creating this warning system, and the MHC-1 molecules remain inside the cell (bottom images).


More Articles About: Lab Report HIV and AIDS All Research Topics infectious disease
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories Microscope
Health Lab
Nerve damage reduced in prediabetic mice with diet, exercise
A low calorie diet and high intensity exercise can reduce nerve damage in prediabetic mice, according to a Michigan Medicine study.
frozen dial with ice on it with red dial
Health Lab
Enzyme identified as new therapeutic target for “cold” tumors
A study identifies an enzyme as a new therapeutic target for “cold” tumors.
On left, a young boy in a wheelchair has his doctor standing to his left and his parent is standing to his right in a show of support. On the right side of the image, the boy is now an adult and is wondering about the cost of his care and if his questions will be answered.
Health Lab
Changing the definition of cerebral palsy
Cerebral palsy is defined as a childhood disorder, which fails to recognize adults living with the condition and the lack of care they receive once they age out of pediatric clinics.
kid screaming with fire coming out of mouth with smoke all around in grey and teddy bear panicked and parents legs on floor as if passed out or blown away
Health Lab
Does your child manage anger well?
One in seven parents think their child gets angrier than peers of the same age and four in 10 say their child has experienced negative consequences when angry, a national poll suggests. 
baby laying down with stethoscope over chest doctors hands
Health Lab
Comparing life threatening illness risk between two surgeries for infants with congenital heart disease
Newly presented data suggest that infants who receive a hybrid stage I palliation – a less invasive alternative for initial treatment – more commonly develop necrotizing enterocolitis compared to those who receive the standard Norwood operation, a complex open heart surgery.
pigs sick and chickens in background with blue background and green cells floating around
Health Lab
Why the bird flu’s jump to pigs is concerning
A Michigan Medicine virologist speaks about the implications of H5N1 influenza, or bird flu, and whether a new pandemic could be on the horizon.